FDA approves new oral three-drug regimen for extensively drug-resistant TB
The treatment involves pretomanid tablets in combination with bedaquiline and linezolid, collectively referred to as the BPaL regimen, and has an …
India tops nations burdened by TB
Absence of new drugs and vaccines, funds shortage affecting treatment and control
Scientists identify new route to tackle TB
Researchers analysed the genome of Mycobacterium tuberculosis and identified three G-quadruplex motifs that could be used as drug targets
Tuberculosis control in India: towards universal access
Revised TB control programme needs to evolve an inclusive business model to engage the Indian private sector to ensure better quality of TB care
Centre agrees to provide restricted TB drug to a Bihar girl; expert advices caution
The Health Ministry promises to make bedaquiline available to 70 centres across India
Gains in tuberculosis control threatened by drug resistance
Drug resistant TB is now a transmitted diseases and requires commitment, especially in high-burden countries like India
New estimate suggests a quarter of the world's population has latent tuberculosis
Eradicating TB won't happen unless the number of people who are latent carriers is tackled. A new estimate suggests it's a much bigger problem …
The new tuberculosis drug is effective, but unaffordable
The drug "delamanid" is not registered in countries with high tuberculosis rates, limiting its access
Scientists find new way to improve efficacy of TB treatment
The new add-on therapy consists of injecting ‘heat-killed’ bacteria into patients along with standard TB drugs
TB drugs stock-outs trigger protests
Paediatric drug buffer stocks to last one month; emergency drug procurement by July 15
Antibiotic resistance: South Africa has a success story in treating resistant TB
Antimicrobial resistance is a worry as in several other African countries
Towards ending childhood tuberculosis
TB is a preventable and curable disease, yet it kills more than 200 children in India every day
WHO recommends faster and cheaper treatment for Multi-Drug Resistant TB
This is a critical step forward in tackling the MDR-TB public health crisis, says organisation
Diagnosing extra-pulmonary TB
TB that affects different parts of the body other than lungs—extra-pulmonary TB—like lymph nodes or bones, accounts for nearly 15 per …
HIV-associated tuberculosis on the rise: India TB Report
Pediatric and drug-resistant TB major concerns for India
Indian pharmacies not responsible for spreading drug resistant TB, finds research
However, they did contribute to delays in TB diagnosis, it concludes
International Tuberculosis Day: An old foe is back, says The Phantom Plague
‘Phantom Plague’ traces the history of tuberculosis from its origins to its global subsidence and the recent rise, especially in …
New treatment against drug-resistant TB successful
Multidrug-resistant TB is a serious public health challenge. It affects vulnerable communities such as migrant workers, refugees, prisoners and …
New cure raises hopes for MDR-TB patients
PaMZ regimen showed better results among HIV-infected patients
India leads list of nations where TB cases go unreported: WHO
Global Tuberculosis Report says 900,000 cases in India are either not diagnosed or not reported to health authorities
MDR-TB cases in India increase more than five-fold in two years
Minister says better surveillance and detection is the reason
Antibiotic resistance a big threat to TB treatment in India
TB programme grappling with lack of funds; weak enforcement of standards another problem
Medicine for drug-resistant TB added to government programme
The drug will be introduced in six tertiary care centers across India
Why India must keep investing in health innovations
Only by committing ourselves to funding health innovation in the long term will India be able to realise today’s most urgently-needed solutions
WHO roadmap to end TB in children focuses for 1st time on pregnant, post-partum women affected by disease
Maternal, pregnancy, birth & infant outcomes should be included in dedicated safety studies for all new TB drugs & vaccines: WHO